Sleep Promotion to Improve Diabetes Management in Adolescents With T1D
Sleep Coach: Sleep Promotion to Improve Diabetes Management in Adolescents With T1D
1 other identifier
interventional
40
1 country
1
Brief Summary
Adolescents with type 1 diabetes (T1D) are at increased risk for problems with adherence and suboptimal glycemic control, and novel approaches are needed to improve outcomes in this high-risk population. The majority of adolescents obtain insufficient sleep (defined as \<8 hours/night), and sleep disturbance has been significantly associated with poorer adherence and predicted greater problems with quality of life and worse glycemic control. Yet, no interventions have addressed sleep in youth with T1D. Working from a biopsychosocial and contextual model of sleep, the investigators propose to tailor a sleep-promoting intervention to meet the needs of adolescents with T1D by conducting interviews with to identify the barriers and facilitators to adequate sleep specific to this population. The sleep-promoting intervention will be developed and tested, building on successful sleep interventions in other populations, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, while addressing the needs unique to adolescents with T1D, such as fear of hypoglycemia. The study will be conducted by a multidisciplinary team, consisting of Sarah Jaser, PhD, a pediatric psychologist, and two co-investigators, Beth Malow, MD, MS, a neurologist with specialty in sleep medicine, and Jill Simmons, MD, a pediatric endocrinologist. Sleep is a potentially modifiable risk factor that may have both a physiological and behavioral impact on diabetes outcomes. Given the strong associations between sleep and diabetes outcomes in the preliminary data, and recent evidence from sleep restriction studies indicating the impact of insufficient sleep on insulin sensitivity, behavior, and mood, there is reason to believe that a sleep-promoting intervention has the potential to improve outcomes in adolescents with T1D indirectly by improving adherence and directly through its effect on metabolic function. Therefore, the proposed study offers a novel approach to improve adherence, quality of life, and glycemic control in adolescents with T1D.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2016
CompletedFirst Posted
Study publicly available on registry
June 1, 2016
CompletedStudy Start
First participant enrolled
October 19, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 5, 2019
CompletedResults Posted
Study results publicly available
October 18, 2019
CompletedJanuary 18, 2020
January 1, 2020
1 year
May 18, 2016
September 16, 2019
January 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Sleep Quality: Baseline
Sleep quality will be measured with the Pittsburgh Sleep Quality Index total score. Each of the sleep components yields a score ranging from 0 to 3, with 3 indicating the greatest dysfunction. The sleep component scores are summed to yield a total score ranging from 0 to 21 with the higher total score (referred to as global score) indicating worse sleep quality.
baseline
Sleep Quality 3 Months
Sleep quality will be measured with the Pittsburgh Sleep Quality Index total score. Each of the sleep components yields a score ranging from 0 to 3, with 3 indicating the greatest dysfunction. The sleep component scores are summed to yield a total score ranging from 0 to 21 with the higher total score (referred to as global score) indicating worse sleep quality.
3 months
Glycemic Control (HbA1c) Baseline
HbA1C is a measure of average blood glucose levels. It is measured quarterly at regular clinic visits.
Baseline
Glycemic Control (HbA1c) 3 or 6 Months
HbA1C is a measure of average blood glucose levels. It is measured quarterly at regular clinic visits.
3 months or 6 months
Sleep Duration: Baseline
Sleep duration will be measured with actigraphy (total sleep time)
baseline
Sleep Duration: 3 Months
Sleep duration will be measured with actigraphy (total sleep time)
3 months
Secondary Outcomes (3)
Quality of Life (PedsQL)
Baseline and 3 months
Adherence (Self Care Inventory) Parent
Baseline and 3 months
Adherence (Self Care Inventory) Teen
Baseline and 3 months
Study Arms (2)
Sleep Promotion
EXPERIMENTALBehavioral sleep-promoting intervention, including components such as limiting caffeine, establishing a media curfew, and positive bedtime routines, as well as needs unique to adolescents with T1D, such as fear of hypoglycemia.
Usual Care
NO INTERVENTIONUsual Care
Interventions
Behavioral intervention to improve sleep quality and duration.
Eligibility Criteria
You may qualify if:
- Diagnosed with type 1 diabetes for at least 12 months
- Speak and read English
- Report Insufficient sleep (\< 8 hours/night most school nights)
You may not qualify if:
- Other major health problems or sleep disorders (other than insomnia)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
pilot study with small sample size
Results Point of Contact
- Title
- Sarah S Jaser
- Organization
- Vanderbilt University Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah S Jaser, PhD
Vanderbilt University Medical Center
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 18, 2016
First Posted
June 1, 2016
Study Start
October 19, 2017
Primary Completion
October 23, 2018
Study Completion
February 5, 2019
Last Updated
January 18, 2020
Results First Posted
October 18, 2019
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share